In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the same
PHILADELPHIA — The volunteers were handing out the staples of harm reduction: safe injection and…
Author: STAT
STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
SAN FRANCISCO — Scientific meetings about Alzheimer’s disease can be funereal affairs, with researchers from…
STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
Gilead Sciences won a key round in its battle with the U.S. government over allegations…
Listen: Wither PhRMA, Alzheimer’s treatment data revealed, and the first fecal microbiome drug approval
A big Alzheimer’s treatment data reveal. The first FDA-approved fecal microbiome drug. And a stinging…
‘A constant information lag’: The troubled recall of Philips CPAP machines underscores flaws in device oversight
The ongoing recall of millions of breathing devices made by Philips has been botched and…
.jpg)
Abortion rights groups look to next fights after 2022 wins
CHICAGO — Emboldened by the results of November’s midterms, abortion rights supporters say they are…
STAT+: With early data and a possible advantage, Amgen enters the obesity drug race
Amgen released detailed data on Thursday suggesting an early-stage drug can induce significant weight loss…
STAT+: Pharmalittle: Roche Alzheimer’s drug didn’t clear enough amyloid; startup to seek approval of nasal swab version of naloxone
Good morning, Jason Mast here filling in for Ed. There are many types of coffee…
Opinion: The U.S. doesn’t need a new ‘essential hospital’ designation
A recent essay in Health Affairs, a prominent health care journal, proposed a useful-sounding idea:…
STAT+: Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information
At a time when many Americans are clamoring for more transparency into prescription drug pricing,…
Elon Musk says Neuralink’s brain-machine implant could enter human studies next year
Elon Musk’s brain-machine interface company Neuralink aims to put its first implant in a human…
STAT+: Roche’s failed Alzheimer’s studies lend weight to an emerging idea about potential treatments
SAN FRANCISCO — The failure of a once-promising Alzheimer’s disease medicine from Roche appears to…
STAT+: ‘This actually changes everything’: Altered image in 1999 paper raises potential peril for Stanford president
New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add…
FDA approves first microbiome drug from Ferring Pharmaceuticals
The Food and Drug Administration approved the first therapy using bacteria from stool samples to…
Covid evolution wipes out another antibody treatment, threatening the country’s medicine cabinet
The Food and Drug Administration on Wednesday ended its emergency authorization for the only remaining…
CDC launches initiative to test wastewater for polioviruses in some communities
With growing concern about the circulation of vaccine-derived polioviruses in the United States, the Centers…
Stanford is investigating its president over allegations of research misconduct
Stanford University has opened an investigation into its president, Marc Tessier-Lavigne, a renowned neuroscientist and…
STAT+: Pharmalittle: Detailed data on Alzheimer’s drug hold up to scrutiny; Horizon in takeover talks with three pharma giants
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
Opinion: Better lab test standards can ensure precision medicine is truly precise
Cancer is becoming less deadly in America. According to the recently released Annual Report to…
‘The more voice, the better’: How tech could bring a fuller picture of living with a disability to health records
Electronic health records don’t leave much room for nuance: On paper, two patients with the…
Opinion: Excise taxes on tobacco, alcohol, and sugary beverages benefit health and public budgets
The Covid-19 pandemic blew up budget deficits in low- and middle-income countries, pushing many toward…
With no exit strategy from ‘zero Covid’ policy, China could face tsunami in cases, experts fear
As the world watches the rare spectacle of protesters challenging China’s authoritarian leadership over its…
STAT+: On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues
In the spring of 1981, a geneticist from Indianapolis and a neurologist from Chicago got…
STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny
SAN FRANCISCO — A closely watched new treatment for Alzheimer’s disease held up to scrutiny…
STAT+: Horizon Therapeutics in acquisition talks with Amgen, Janssen, and Sanofi
Amgen, Janssen, and Sanofi are in talks to acquire Horizon Therapeutics, the Irish drugmaker confirmed…
Google Cloud’s health strategy, NIH’s Covid data dilemma, & rumored telehealth mergers
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback
He Jiankui, the Chinese biophysicist who created the first gene-edited children, had been quiet since…
STAT+: Pharmalittle: PhRMA trade group is losing its edge; Eisai CEO tries to silence critics of Alzheimer’s drug
Hello, everyone, and how are you today? Gray skies are hovering over the Pharmalot campus…
Opinion: Rushing into the World Bank’s Pandemic Fund is a bad idea
The World Bank has rolled out a new Financial Intermediary Fund for Pandemic Prevention, Preparedness,…
Resistance to FDA’s opioid-disposal plan raises concerns about CADCA, a powerful advocacy group
At its surface, it seems like a simple problem with a simple solution. Across the…
STAT+: PhRMA, once invincible in Washington, has lost its edge
WASHINGTON — PhRMA has a reputation in Washington for might, for money, for scorched-earth tactics,…
.jpg)
STAT+: mRNA startup Strand Therapeutics raises millions to test targeted cancer therapies
When Jacob Becraft addressed a bustling party of a hundred-plus employees, friends, and investors at…
STAT+: ‘Skinny labels’ on biosimilar medicines saved Medicare $1.5 billion over a recent five-year period
A hotly contested provision of a federal law designed to speed copycat drugs to market…
STAT+: The secret to longer, healthier life? Ambitious new trial focuses on ‘super agers’ and seeks thousands of families.
Dr. Thomas Perls has for decades studied so-called super agers, people who live deep into their 90s…
China eases Covid rules after wide protests of lockdowns
BEIJING — Chinese authorities eased some anti-virus rules but affirmed their severe “zero Covid” strategy…
STAT+: Pharmalittle: Second clinical trial death may be linked to Eisai-Biogen Alzheimer’s drug; pharma presses the U.K. over ‘out of control’ levy
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
Opinion: Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage
Eisai’s announcement that lecanemab, its antibody drug for Alzheimer’s disease that targets the buildup of…
STAT+: Axsome drug reduces agitation in Alzheimer’s patients, data show
A drug developed by Axsome Therapeutics significantly reduced a common side effect of Alzheimer’s disease…
WHO to phase out the name ‘monkeypox’ for ‘mpox’
The World Health Organization said Monday it will phase out the name of the disease…
STAT+: Former Merck CEO: Democracy and the drug industry are both in danger
Ken Frazier, the former chief executive of Merck, has been the preeminent pharmaceutical CEO of…
Opinion: Minimizing administrative harm: a key step to improving health care
Late on a Friday, I sit reviewing some of my patients’ old medical records instead…
Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis…
Q&A: Siddhartha Mukherjee on the rapid pace of cancer research and ‘luminous’ life of cells
The first cells Siddhartha Mukherjee ever saw were T cells, pulled from a mouse spleen…
Experimental flu vaccine, developed using mRNA, seen as potential game changer
An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should…
STAT+: UPMC, Advocate Aurora, Duke fighting lawsuits over use of Meta’s tracking tool
Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information…
STAT+: Pharmalittle: FDA approves first gene therapy for hemophilia B; pharma’s reputation slips in U.S.
Happy Thanksgiving Eve from STAT reporter Andrew Joseph, filling in for the day. A note…
A jury finds NCAA is not to blame in lawsuit over football player’s death after repeated head trauma
LOS ANGELES — In a verdict that could affect countless claims by athletes who sue…
Opinion: Deans: Dump that USNWR ‘best medical school’ survey
Yale and Harvard Law Schools recently announced they would no longer participate in U.S. News…
‘Mass incarceration is one of the greatest health challenges of our time’: MacArthur ‘genius’ Emily Wang on building solutions
The U.S. has two separate health care systems: one for people who aren’t incarcerated, and…
Opinion: The real experts: people living with mental illness
When Ken Duckworth was a child, his family didn’t talk about mental health, especially not…